111 related articles for article (PubMed ID: 20647543)
1. The molecular basis of phospholipase D2-induced chemotaxis: elucidation of differential pathways in macrophages and fibroblasts.
Knapek K; Frondorf K; Post J; Short S; Cox D; Gomez-Cambronero J
Mol Cell Biol; 2010 Sep; 30(18):4492-506. PubMed ID: 20647543
[TBL] [Abstract][Full Text] [Related]
2. The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).
Gomez-Cambronero J
Cell Signal; 2011 Dec; 23(12):1885-95. PubMed ID: 21740967
[TBL] [Abstract][Full Text] [Related]
3. Mutation of Y179 on phospholipase D2 (PLD2) upregulates DNA synthesis in a PI3K-and Akt-dependent manner.
Di Fulvio M; Frondorf K; Gomez-Cambronero J
Cell Signal; 2008 Jan; 20(1):176-85. PubMed ID: 18006275
[TBL] [Abstract][Full Text] [Related]
4. Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them.
Zhang Y; Redina O; Altshuller YM; Yamazaki M; Ramos J; Chneiweiss H; Kanaho Y; Frohman MA
J Biol Chem; 2000 Nov; 275(45):35224-32. PubMed ID: 10926929
[TBL] [Abstract][Full Text] [Related]
5. The role and regulation of phospholipase D in metabolic disorders.
Park SH; Kang JH; Bae YS
Adv Biol Regul; 2024 Jan; 91():100988. PubMed ID: 37845091
[TBL] [Abstract][Full Text] [Related]
6. Mechanical activation of TWIK-related potassium channel by nanoscopic movement and rapid second messenger signaling.
Petersen EN; Pavel MA; Hansen SS; Gudheti M; Wang H; Yuan Z; Murphy KR; Ja W; Ferris HA; Jorgensen E; Hansen SB
Elife; 2024 Feb; 12():. PubMed ID: 38407149
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of Ccn4 and Other Genes Between Metastatic and Non-metastatic EL4 Mouse Lymphoma Cells.
Chahal MS; Ku HT; Zhang Z; Legaspi CM; Luo A; Hopkins MM; Meier KE
Cancer Genomics Proteomics; 2016 11-12; 13(6):437-442. PubMed ID: 27807066
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional motility of a macrophage cell line on microcontact-printed fibronectin.
Hind LE; Mackay JL; Cox D; Hammer DA
Cytoskeleton (Hoboken); 2014 Sep; 71(9):542-54. PubMed ID: 25186818
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase D2 controls bone homeostasis by modulating M-CSF-dependent osteoclastic cell migration and microtubule stability.
Kim HJ; Lee DK; Jin X; Che X; Ryu SH; Choi JY
Exp Mol Med; 2022 Aug; 54(8):1146-1155. PubMed ID: 35945449
[TBL] [Abstract][Full Text] [Related]
10. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract][Full Text] [Related]
11. PLD1 and PLD2 differentially regulate the balance of macrophage polarization in inflammation and tissue injury.
Hwang WC; Seo SH; Kang M; Kang RH; Di Paolo G; Choi KY; Min DS
J Cell Physiol; 2021 Jul; 236(7):5193-5211. PubMed ID: 33368247
[TBL] [Abstract][Full Text] [Related]
12. Mammalian phospholipase D: Function, and therapeutics.
McDermott MI; Wang Y; Wakelam MJO; Bankaitis VA
Prog Lipid Res; 2020 Apr; 78():101018. PubMed ID: 31830503
[TBL] [Abstract][Full Text] [Related]
13. Physiological function of phospholipase D2 in anti-tumor immunity: regulation of CD8
Ngo Thai Bich V; Hongu T; Miura Y; Katagiri N; Ohbayashi N; Yamashita-Kanemaru Y; Shibuya A; Funakoshi Y; Kanaho Y
Sci Rep; 2018 Apr; 8(1):6283. PubMed ID: 29674728
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase D is Dispensable for Epidermal Growth Factor-Induced Chemotaxis.
Hirai C; Badawy SMM; Zhang L; Okada T; Kajimoto T; Nakamura S
Kobe J Med Sci; 2017 May; 62(6):E162-E167. PubMed ID: 28490713
[TBL] [Abstract][Full Text] [Related]
15. The transcription factors Slug (SNAI2) and Snail (SNAI1) regulate phospholipase D (PLD) promoter in opposite ways towards cancer cell invasion.
Ganesan R; Mallets E; Gomez-Cambronero J
Mol Oncol; 2016 May; 10(5):663-76. PubMed ID: 26781944
[TBL] [Abstract][Full Text] [Related]
16. A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression.
Ciavarella S; Caselli A; Tamma AV; Savonarola A; Loverro G; Paganelli R; Tucci M; Silvestris F
Stem Cells Dev; 2015 Jun; 24(12):1457-70. PubMed ID: 25758779
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.
Bruntz RC; Lindsley CW; Brown HA
Pharmacol Rev; 2014 Oct; 66(4):1033-79. PubMed ID: 25244928
[TBL] [Abstract][Full Text] [Related]
18. A river runs through it: how autophagy, senescence, and phagocytosis could be linked to phospholipase D by Wnt signaling.
Gomez-Cambronero J; Kantonen S
J Leukoc Biol; 2014 Nov; 96(5):779-84. PubMed ID: 25082152
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.
Gomez-Cambronero J
J Biol Chem; 2014 Aug; 289(33):22557-22566. PubMed ID: 24990944
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model.
Henkels KM; Boivin GP; Dudley ES; Berberich SJ; Gomez-Cambronero J
Oncogene; 2013 Dec; 32(49):5551-62. PubMed ID: 23752189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
